UNSPSC 51143105: Diflunisal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H8F2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C546U4DEN, chemically known as 5-(2,4-difluorophenyl)salicylic acid but generally known as diflunisal, which bears US NIH Compound Identifier 3059. European Medicines Agency schedules Diflunisal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07130MIG.

UNSPSC 51143105 Diflunisal (Commodity) shows a substantial mismatch between its nominal scope — a nonsteroidal anti-inflammatory drug — and actual state and local procurement activity under the code. The most recent opportunities tagged to this code are a City of Austin IFB for liquid aluminum sulfate (alum) for wastewater treatment and a City of Tampa ITB for medical aid supplies including aspirin, pain relievers, bandages, and first aid kits. Neither the alum solicitation nor the Tampa medical supplies opportunity involves diflunisal specifically or pharmaceutical procurement aligned with the code's definition. The Tampa opportunity does reference pain relievers and aspirin within a broader fire rescue medical supply category, but this represents a misclassification rather than genuine diflunisal procurement. State and local procurement activity under this code does not support a coherent purchasing pattern around the drug itself.

The geographic spread reflected in recent opportunities is limited to Texas (City of Austin) and Florida (City of Tampa), with both solicitations originating from municipal issuing bodies rather than state agencies, school districts, or transit authorities. The Austin alum contract, due August 25, 2026, reflects a specialized municipal utility need unrelated to pharmaceutical products. The Tampa medical supplies ITB, originally due April 9, 2025 (now closed), covered a $100,000 department budget with set-asides for Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises. The code appears to carry minimal decision relevance for firms pursuing state and local pharmaceutical or diflunisal procurement; the tagging appears to reflect data-entry error or system misconfiguration rather than active buying patterns.